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Bovine spongiform encephalopathy (BSE) clearly originated in the UK, where there have
now been more than 180 000 cases. However, through the exportation of cattle and cattle-
feed additives from the UK, BSE also became established to a lesser extent in other
European countries. There is current concern that BSE might have been distributed more
widely as a result of the exportation of cattle or BSE-infected feed or foodstuff not only
from the UK but also from other European countries that later became affected. It is now
recognized that the transmissible agent that causes BSE also causes a new variant form of
Creutzfeldt–Jakob disease (vCJD) in humans, and the evidence for this is presented. This
probably resulted from dietary exposure to the bovine agent, and the potential role of
mechanically recovered meat is discussed. There is a brief discussion on the controversial
issue of the nature of the causal agents of diseases like BSE and vCJD. Whether or not
sheep or goats could have become infected with BSE, and whether they represent a
human health hazard, is also debated. Finally, the question of the control of BSE, and
consequently vCJD, is discussed with regard to the rigorous application of the relevant
regulations.
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I N T R O D U C T I O N
Sporadic Creutzfeldt–Jakob disease (CJD) of
humans, and bovine spongiform encephalopathy
(BSE), are two members of a distinct and wider
group of fatal transmissible degenerative encepha-
lopathies (TDEs) of animals and humans (Table 1).
Sporadic CJD affects around one per million of the
human population worldwide each year, causing
death at a median age of around 66. It was reported
in 1996 that ten cases of a new variant form of CJD
(vCJD) had been recently identified in relatively
young individuals in Great Britain but not appar-
ently elsewhere [1]. This was of widespread inter-
est because: (1) the clinical signs of vCJD were
unlike those of sporadic CJD; (2) the period of
clinical disease before death was much longer than
for sporadic CJD; (3) death occurred at a median
age of 29; (4) the neurohistopathologic features of
vCJD were different from those in sporadic CJD;
and (5) it was concluded that, in the absence of any
other obvious cause, the most likely explanation
for vCJD was dietary exposure to the agent that
had caused a major epidemic of BSE in the UK.
The first cases of BSE were identified around
1985; the epidemic peaked in 1993, and is currently
in steep decline. The incidence of BSE in the UK
cattle population has, thus far, considerably
exceeded that in any other BSE-affected country
(Table 2), with around 180 000 cases having been
confirmed by April 2001.
By September 2001, the number of confirmed
vCJD cases in the UK had escalated to 109; three
cases had also been identified in France, one in
Ireland, and one in Hong Kong. Until 2000, the rate
of occurrence of vCJD had been relatively con-
stant, but by July 2000, the number of cases already
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observed in that year suggested that the incidence
was increasing. This indicated that the eventual
scale of the epidemic might be far from modest but
that further time would have to elapse to deter-
mine whether or not the apparently escalating
incidence would continue. As of September
2001, the increased incidence of confirmed vCD
first reported between January and June 2000 was
being maintained but did not appear to be gather-
ing further momentum. However, it is impossible
at present to predict what the eventual scale of the
vCJD problem will be in countries where it already
exists, or in other countries within which it might
appear in the future. Studies on the UK cases of
vCD have, thus far, failed to implicate anything
other than BSE-contaminated foodstuff as the
likely cause of the disease. This likelihood is
reinforced by the knowledge that TDE agents
are able to withstand the temperatures used to
cook food by boiling, oven-roasting, pressure-
cooking or microwaving [2]. The escalating inci-
dence of vCJD has been of particular interest in
European countries that appear to have failed,
thus far, to have controlled BSE (Table 2). How-
ever, it has to be appreciated that BSE has only
been detected in some countries as a result of the
recent introduction of systems for testing the brain
tissue of apparently healthy cattle at the time of
slaughter for human consumption.
It remains an open question as to whether the
BSE agent was already present as a covert bovine
pathogen before the UK epidemic occurred, or
whether it arose as a result of the survival of a
single thermostable strain of scrapie agent from
Table 1 Transmissible degenerative
encephalopathies Disease Affected species
Scrapie Sheep, goats, moufflon
Transmissible mink encephalopathy (TME) Mink
Chronic wasting disease (CWD) Elk, mule-deer (in the USA)
Bovine spongiform encephalopathy (BSE) Cattle, captive exotic ruminants
Feline spongiform encephalopathy (FSE) Cats, captive exotic felids
Creutzfeldt–Jakob disease (CJD) Humans
Variant CJD (vCJD) Humans
Gerstmann–Straussler–Scheinker
syndrome (GSS)
Humans
Fatal familial insomnia (FFI) Humans
Sporadic fatal familial insomnia Humans
Kuru Humans
Table 2 The number of cases of indigenous BSE recorded in different countries each year between 1994 and 2001
1994 1995 1996 1997 1998 1999 2000 2001a
Great Britain 23 945 14 302 8016 4312 3179 2133 1311 311
Northern Ireland 345 173 74 23 18 7 14 6
Belgium 0 0 0 1 6 3 9 19
Slovakia 0 0 0 0 0 0 0 1
Denmark 0 0 0 0 0 0 1 2
France 4 3 12 6 18 31 161 69
Germany 0 0 0 0 0 0 7 90
Greece 0 0 0 0 0 0 0 1
Irish Republic 18 15 73 80 83 91 149 56
Italy 0 0 0 0 0 0 0 20
Liechtenstein 0 0 0 0 2 0 – –
Luxembourg 0 0 0 1 0 0 0 0
The Netherlands 0 0 0 2 2 2 2 11
Portugal 12 14 29 30 106 170 163 44
Spain 0 0 0 0 0 0 2 54
Switzerland 64 68 45 38 14 50 54 19
aUntil June.
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sheep. Such a strain would have had to be able to
survive the rendering processes used to manufac-
ture meat and bone meal (MBM) that was fed to
cattle and other species. The BSE inquiry that was
conducted in the UK concluded that it was not
plausible that BSE had been caused initially by a
scrapie agent derived from sheep. However, it was
later concluded that a sheep-derived agent was the
more likely source of the epidemic [3]. It is clear
that the rapid expansion of the UK epidemic of
BSE was due to feeding cattle with MBM that had
been manufactured by the rendering industry
from the tissues of BSE-infected cattle discarded
mainly by abattoirs [4]. Based upon its clinical
symptoms, there have been anecdotal reports that
BSE has occurred in the past. However, such
reports cannot be seriously considered, because
UK field veterinarians with considerable experi-
ence of BSE still misdiagnose around 20% of sus-
pects on the basis of their clinical symptoms. Also,
archival studies on the brain tissue of cattle failed
to reveal any neurohistopathologic evidence that
BSE existed in the past in Great Britain [5].
Indigenous BSE does not appear to have gen-
erally occurred in countries that unwittingly
imported infected cattle from the UK that later
developed BSE (Table 2); the exception may be
Portugal (Schreuder, personal communication).
Thus, the epidemics that have occurred in other
countries are more likely to have been precipitated
through their importation of MBM from the UK,
before this practice was prohibited. It is relevant
that UK renderers exported more MBM into the
international market in 1989 than ever before, even
though the BSE risks must have been known to
their customers because of the British ban on
feeding ruminant-derived proteins to ruminants
introduced in 1988. The international brokering
system for MBM did not necessarily permit the
identification of countries that imported UK-
derived MBM during 1989 or in any other years.
However, BSE has only occurred so far in Eur-
opean countries, and has been shown (when
tested) to have been caused by the single strain
of infectious agent found in Britain. This appears
to constitute relatively convincing evidence that
BSE became established in other European coun-
tries through their importation of UK-derived
MBM before such trading was prohibited.
The occurrence of vCJD is of considerable inter-
national scientific interest, because it represents
the only known example of the transmission of an
animal TDE to humans. This contrasts with the
long-standing experience that occupational or
dietary exposure of humans to the agent that
causes scrapie in sheep, goats and moufflon does
not appear to result in the transmission of scrapie
to humans, despite the endemic nature of scrapie
in a number of countries [6].
T H E N A T U R E O F T D E A G E N T S
TDE agents have been considered to be simply
rogue forms of the host’s normal PrP protein that
resist catabolic destruction by proteolytic enzymes
[7]. This has been considered to result from post-
translational structural changes in the PrP protein
that are induced by contact with the already-
modified, disease-specific forms of PrP [8]. The
progressive accumulation of the modified, amy-
loidogenic form of PrP eventually results in the
formation of pathologic deposits in the central
nervous system within which there is the highest
level of expression of PrP. However, the ‘protein-
only’ hypothesis relating to the nature of TDE
agents is not universally accepted because it fails
to adequately explain the individual phenotypic
characteristics of the many strains of TDE agents
that can be propagated in mice with the same PrP
genotype, and the stability of the strain-specific
phenotype of the BSE agent in mice regardless of
its previous history of passage through various
mammalian species with different PrP genotypes
[9]. Some therefore consider that, although it is
generally agreed that a modified form of PrP is
an essential component of the infectious agents,
additional (possibly non-host) informational mole-
cules such as nucleic acids are required to explain
strain diversity [10–13] but none have yet been
identified.
D I E T A R Y T R A N S M I S S I O N O F B S E
A N D V C J D
With BSE, there is convincing evidence that the
epidemic was fueled by feeding cattle with MBM
produced from the tissues of BSE-infected cattle
[4]. This is reinforced by the fact that a significant
downturn in the incidence of BSE was experienced
5 years after a ruminant-to-ruminant feed-ban was
introduced in the UK in 1988. The significance of
this reduced incidence was that it had already
been observed that the average age at which cattle
developed BSE was around 5 years. This indicated
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that the rendering procedures used in the UK
during the 1980s had (largely) failed to adequately
inactivate the BSE agent. This was confirmed by
experimental studies on these rendering practices
[14].
Emotive headlines in UK newspapers during
the mid-to-late 1980s suggested that there should
be concern about the consumption of beef with
regard to the transmission of BSE to humans.
However, the product recognized traditionally
as prime beef in the UK would be the muscle
tissue of relatively young cattle that were unlikely
to have been fed MBM. Even if such cattle were
potentially infected, their usual age at slaughter
would have meant that they were unlikely to be
harboring detectable levels of BSE infectivity in
any of their tissues. In considering potential
human health hazards, attention should have been
focused on products other than beef obtained from
older dairy cattle that were likely to have been fed
MBM. Such animals were usually slaughtered at
an age where they could be close to displaying
clinical signs of BSE, and therefore have infectivity
in their central nervous system.
As will be discussed later, there is overwhelm-
ing evidence that vCJD is caused by the BSE agent.
Studies initiated in 1996 have still failed to impli-
cate anything other than dietary exposure to the
BSE agent as the cause, but its association with any
particular type of food product has not been
demonstrated. One problem is that, in common
with other human TDEs, vCJD is likely to have
long and variable incubation periods that could
extend to decades. The most significant period of
exposure of the UK population to the BSE agent
would have been in the 1980s when the BSE epi-
demic was expanding rapidly, until late 1989 when
the first significant measures to protect human
health were introduced. At the CJD Surveillance
Unit in Edinburgh, the dietary habits of indivi-
duals who became vCJD victims have been com-
pared with controls without demonstrating any
apparent significant differences. Nevertheless,
there are intellectual or recall-bias problems in
interviewing cases, or their relatives, regarding
the eating habits of such individuals up to 20 years
ago. However, it was observed that mechanically
recovered meat (MRM) that was likely to have
been commonly incorporated into cheap food pro-
ducts had featured significantly in the diets of both
the vCJD cases and the controls. It was recognized
that MRM was likely to have contained particles of
bovine spinal cord or dorsal root ganglia that
could contain potentially high levels of the BSE
agent, and its incorporation into human foodstuff
was prohibited in Great Britain in 1994. Also, when
the apparently upward-spiraling increase in the
incidence of vCJD was reported in July 2000,
consultants from the CJD Surveillance Unit in
Edinburgh were reported in the media to have
again suggested that a significant factor might
have been ‘institutional cuisine’ consumed in the
past, whereby organizations such as employee
canteens and school-meal services may have opted
to use cheaper food products that were more likely
to have contained MRM. There is thus the enigma
that, although respected experts appear to believe
that MRM has been a potentially significant diet-
ary vehicle whereby BSE might have been trans-
mitted to humans to cause vCJD, this is not
reflected in the studies in which the dietary habits
of cases were compared with those of controls.
However, the number of cases of vCJD is not high
enough to exclude chance or random factors in its
etiology. With regard to the potential consumption
of MRM, the distribution of BSE infectivity in any
given batch was unlikely to have been homoge-
neous. Thus, in social groups consuming food
containing infected MRM at the same meal, most
might have received portions that contained either
no BSE infectivity, or an insufficient amount to
establish vCJD infection. In contrast, another indi-
vidual might have consumed a portion of the same
food that contained sufficient infectivity to have
infected a number of people if the BSE infectivity
had been more evenly dispersed throughout the
food product. The situation may have also been
clouded by the operation of other factors. For
example, vCJD has only occurred thus far in indi-
viduals who are homozygous for methionine at
codon 129 of their PrP genes. However, experience
with the accidental transmission of human TDEs
to humans suggests that vCJD is also likely to
occur in valine homozygotes and methionine/
valine heterozygotes. The simple explanation as
to why vCJD has not yet apparently occurred in
such genotypes is that the incubation period may
be longer in such individuals. A more worrisome
alternative is that the clinical and neurohisto-
pathologic features of CJD in these genotypes
might not be sufficiently distinctive to differentiate
it from sporadic CJD. If this proved to be the case,
evidence of its occurrence might only be revealed
by the relatively long-term observation of an
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unexpected increase in the incidence of (appar-
ently) sporadic CJD.
Other factors, including genetic differences at
loci other than that of the PrP gene, might influ-
ence the likelihood of individuals succumbing to
vCJD. Also, although vCJD is clearly a neurologic
disease, its pathogenesis appears to involve an
important earlier stage of agent replication within
the lymphoreticular system [15,16]. Thus, if the
immune system of individuals happened to be
stimulated at the time of their exposure to the
BSE agent, this might render them more suscep-
tible to infection. In addition, in what appears to be
a food-borne disease, lesions within the gastroin-
testinal tract at the time of exposure might enhance
the likelihood of infection.
Until vCJD emerged, no studies had been con-
ducted to determine the precise mechanisms
whereby TDE infections might become established
after dietary exposure. In this respect, experimen-
tal studies have now been carried out to deter-
mine: (1) the route or routes by which infection
reaches the central nervous system, and (2) which
cellular components of the intestinal wall express
PrP at sufficiently high levels to represent likely
routes of entry for TDE agents. Following the oral
challenge of hamsters with hamster-passaged
scrapie agent, it has been demonstrated that the
earliest appearance of the disease-specific form of
PrP in the brain results from transmission through
the vagal nerve; infectivity also appears to consis-
tently, but more slowly, reach the brain by traver-
sing through enteric lymphoid tissue, spleen,
splanchnic nerves and the thoracic region of the
spinal cord, from which it travels to the brain [17].
The latter route has also been found to occur after
peripheral infection with mouse-passaged scrapie,
and these studies have also confirmed the impor-
tance of agent replication in the follicular dendritic
cells of the spleen before infectivity is delivered to
the central nervous system [18,19]. Studies on the
distribution of normal PrP in the intestinal wall of
humans have demonstrated its presence in nerve
endings that form intimate associations with
enteric epithelial cells, and show that only a thin
layer of epithelium stands between ingested TDE
agents and host PrP [20].
In addition to cattle and humans, BSE has
infected domestic cats and a variety of exotic felid
and ruminant species in British zoological collec-
tions. Therefore, the causal agent has frequently
been considered to be particularly promiscuous. In
1988 and 1989, the first significant control mea-
sures were introduced to minimize the exposure of
ruminants to infected feed, and humans to infected
food, respectively. However, before the end of
1989, food was likely to have contained significant
amounts of BSE infectivity. By that time, although
more than 11 000 cases of BSE had been confirmed
in Great Britain, it has been calculated that around
446 000 infected, but apparently normal, cattle
would have been processed in abattoirs to produce
food [21]. Scrapie is endemic in the UK, but its
incidence and the quantity of sheep processed
through abattoirs are not high enough to have
resulted in contamination of the food supply with
scrapie agent to the same extent as BSE, and no
association has been found between sporadic CJD
and dietary or occupational exposure to scrapie
agent [6]. However, it is interesting to speculate
whether the apparent absolute species barrier
between sheep and humans (or other species)
would have been so resilient if the dietary level
of scrapie agent had been as high as that of the BSE
agent.
E V I D E N C E T H A T V C J D I S C A U S E D
B Y T H E B S E A G E N T
The hypothesis proposed in 1996 that vCJD
resulted from exposure to the BSE agent is now
supported by experimental data. It had already
been demonstrated that the patterns of incubation
periods in a panel of inbred strains of mice were
essentially the same when the mice were injected
with brain tissue from: (1) British or Swiss cattle
with BSE; (2) domestic cats from the UK with feline
spongiform encephalopathy (FSE); (3) exotic rumi-
nants with BSE-like diseases; and (4) goats, pigs
and sheep that had been experimentally infected
with the BSE agent. These incubation period pat-
terns were quite unlike those for any other TDE
agent. Similarly, the regional distribution and
severity of spongiform changes in the brains of
each of the different strains of recipient mice were
the same for all of the isolates tested but were
dissimilar to those associated with other TDE
agents. These studies convincingly demonstrated
that the BSE agent is a single strain that has: (1)
affected cattle in Switzerland and the UK; (2)
caused FSE; (3) infected exotic ruminants; and
(4) retained its distinctive phenotype after experi-
mental passage through goats, pigs and sheep [9].
When the brain tissues from cases of vCJD were
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injected into the same panel of mouse strains, the
same picture emerged. This was entirely different
from the pattern resulting from challenge with the
brain tissues from cases of sporadic CJD, and
provided overwhelming evidence that the BSE
agent is the cause of vCJD [22]. Confirmatory
evidence was provided by the demonstration that
the glycosylation patterns of the disease-specific
forms of PrP derived from cattle with BSE and
humans with vCJD were essentially the same, but
different from those derived from animals or
humans with other TDEs [23].
B S E A N D S H E E P
BSE can be experimentally transmitted to goats
and sheep by the oral route through feeding them
as little as 0.5 g of brain tissue from BSE-affected
cattle, and the ensuing disease is clinically and
neurohistopathologically indistinguishable from
scrapie [24]. However, such studies are not neces-
sarily relevant to the question of whether goats or
sheep might have become infected in the past by
feeding them with MBM that was infected with the
BSE agent. This is because the infectivity titer in
MBM could not have been nearly as high as that in
the BSE-infected brain tissue used in the oral
transmission studies. It is difficult to determine
whether transmission of BSE to sheep or goats
might have occurred in countries within which
scrapie, but not BSE in cattle, is endemic, but
where they might have been fed MBM imported
from the UK. The situation is even more compli-
cated in countries where both endemic BSE and
scrapie occur if sheep or goats were fed MBM. In
the UK, where such a situation exists, there are a
number of ongoing studies designed to determine
whether the BSE agent has infected sheep. There is
a theoretical possibility that sheep could have
become infected with the BSE agent through the
incorporation of infected MBM into their feedstuff.
The risk associated with such occurrences in sheep
is much lower than for cattle, because MBM was
fed less commonly to sheep. Also, when MBM was
fed to sheep, the inclusion rates in their rations
were substantially less (except for dairy sheep)
than in bovine feed. In addition, the daily amounts
of potentially BSE-contaminated feed consumed
by sheep would obviously be less than in bovines.
In the seminal study that first established that the
new variant form of CJD is caused by the BSE
agent, the brains of contemporary sheep with
scrapie were also examined but were not found
to be BSE-infected [22]. Since that time, there has
been an ongoing search for BSE in sheep in the UK.
As a consequence of recommendations made by
the UK Spongiform Encephalopathy Advisory
Committee, this program has been expanded
[25] and will involve at least several hundred
sheep. Although there have not yet been any for-
mal reports relating to the current status of these
studies, the Director of the Institute for Animal
Health in the UK has reported to the media that
these have not, as yet, revealed any evidence of the
presence of BSE in sheep, even though a number of
the assays are nearing completion. In addition, a
survey carried out by Dr M. Gravenor of the
Institute for Animal Health has not revealed any
significant increase in scrapie-like disease in
sheep during the period between 1962 and 1998
[26].
With regard to this problem, a further clue
might be provided by strain-typing some of
the agents that have caused singleton cases of
scrapie in 12 different Swiss sheep flocks during
the 1990s. Such a study could be relevant because
Switzerland appeared to be scrapie-free before the
emergence of its BSE epidemic, and it is already
known that the strain type of the BSE agent in
Switzerland is the same as that of the British BSE
agent. Although it would be considered unusual
for only single sheep to become scrapie-affected in
all of these Swiss flocks, the occurrence of single, or
few, cases of BSE in herds of cattle that were fed
potentially BSE-infected MBM is not unusual. This
is considered to have resulted from the uneven
distribution of BSE infectivity throughout any
given batch of MBM by virtue of the manufactur-
ing process [27].
F U T U R E P R O S P E C T S
Since 1993, the year-to-year incidence of BSE in the
UK has significantly declined as a result of the
progressive introduction of rigorous control mea-
sures, but it still remains to be seen whether or not
complete eradication can be achieved. However,
the same consistent downward trend has not been
experienced in all other European countries within
which endemic BSE occurs (Table 2). It remains an
open question as to what the eventual scale of
the epidemics, and the commensurate risks to
human health, remains an open question in these
countries. The EU has introduced measures to
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minimize the expansion of the incidence of BSE in
countries already affected, and to avoid the spread
of this disease to other countries. However, the UK
experience has been that regulatory measures are
only effective if they are adequately monitored.
This is reflected in the current UK position, where
there are frequent visits by government inspectors
to abattoirs, knackers, hunt kennels, rendering
plants, feed-mills and incineration facilities to
ensure compliance with all of the relevant regula-
tions. There is also a policy that, where there is
sufficient evidence, those who have broken the law
will be prosecuted unless their transgressions
were of an innocent nature. The system in the
UK is now such that more than 2000 inspections
of abattoirs have been carried out over the past
year. Although such inspections were unan-
nounced, there was only a 0.7% rate of some
degree of non-compliance with the regulations
[28]. The UK has learned that the introduction of
regulations has to be accompanied by efficient
mechanisms for monitoring their effectiveness.
Thus, in other countries with BSE, it has to be
demonstrated that any control measures are
accompanied by monitoring systems adequate to
confirm that an acceptable degree of compliance is
being achieved. For example, in the UK, where
there was a requirement to exclude potentially
BSE-infected bovine tissues from animal or human
food chains, it was recognized retrospectively that
such standards were not being rigorously
observed until 1996. Thus, potentially BSE-
infected tissues were still frequently being ren-
dered to produce MBM for non-ruminant species
such as pigs and poultry. However, the nature of
the feed-mills in the UK was such that ruminant
diets were generally produced on the same pro-
duction lines as those used for non-ruminants.
This led to the contamination of ruminant diets
with the BSE agent. The simple message from the
experience of the UK is that it is not sufficient to
simply introduce regulations that are intended to
control the way in which the food and animal-feed
industries operate; the introduction of such reg-
ulations has to be accompanied by an efficient,
though costly, inspection system that ensures a
high degree of compliance. The UK has learned
these lessons from bitter experience but it remains
to be seen whether or not other European, or other
‘at-risk’, countries will learn from the UK experi-
ence. The control of BSE in any given country is
likely to be achieved only by the introduction of
appropriate regulatory systems that are monitored
rigorously.
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